Summary | Fosun revises Indian drug maker acquisition, cuts
stake size - Business - Chinadaily.Its revenue mainly es from
the markets of the US and Europe."China and India are
plementary in the field of pharmaceuticals.The termination date
of the deal will be extended to Oct 3, Fosun Pharmaceutical
said.Without written authorization from CDIC, such shall not be ...
chinadaily.com.cn | 18 September 2017